Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Guimbaud

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
ESMO Open|May 27, 2023
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO studyE Alouani, M Mercier, C Flecchia, et al.
Plos One|December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancerL Mineur, E François, C Plassot, et al.
Breast Cancer Research and Treatment|August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic testsP Pujol, D Stoppa Lyonnet, T Frebourg, et al.
International Journal of Surgery (London, England)|April 4, 2024
Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort studyM Mekkan-Bouv Hez, L Derbey, L de Mestier, et al.
Journal of Medical Genetics|August 31, 2015
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohortN Lavoine, C Colas, M Muleris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapyF Poumeaud, T Valentin, N Fares, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
ESMO Open|May 27, 2023
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO studyE Alouani, M Mercier, C Flecchia, et al.
Plos One|December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancerL Mineur, E François, C Plassot, et al.
Breast Cancer Research and Treatment|August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic testsP Pujol, D Stoppa Lyonnet, T Frebourg, et al.
International Journal of Surgery (London, England)|April 4, 2024
Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort studyM Mekkan-Bouv Hez, L Derbey, L de Mestier, et al.
Journal of Medical Genetics|August 31, 2015
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohortN Lavoine, C Colas, M Muleris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapyF Poumeaud, T Valentin, N Fares, et al.
Pageof 6